• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外显子包含特征能够准确估计剪接因子活性。

Exon inclusion signatures enable accurate estimation of splicing factor activity.

作者信息

Anglada-Girotto Miquel, Moakley Daniel F, Zhang Chaolin, Miravet-Verde Samuel, Califano Andrea, Serrano Luis

机构信息

Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Dr. Aiguader 88, Barcelona 08003, Spain.

Department of Systems Biology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, USA 10032.

出版信息

bioRxiv. 2025 Jan 30:2024.06.21.600051. doi: 10.1101/2024.06.21.600051.

DOI:10.1101/2024.06.21.600051
PMID:38979366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11230296/
Abstract

Splicing factors control exon inclusion in messenger RNA, shaping transcriptome and proteome diversity. Their catalytic activity is regulated by multiple layers, making single-omic measurements on their own fall short in identifying which splicing factors underlie a phenotype. Here, we propose splicing factor activity can be estimated by interpreting changes in exon inclusion. We benchmark methods to construct splicing factor→exon networks and calculate activity. Combining RNA-seq perturbation-based networks with VIPER (virtual inference of protein activity by enriched regulon analysis) accurately captures splicing factor activation modulated by different regulatory layers. This approach consolidates splicing factor regulation into a single score derived solely from exon inclusion signatures, allowing functional interpretation of heterogeneous conditions. As a proof of concept, we identify recurrent cancer splicing programs, revealing oncogenic- and tumor suppressor-like splicing factors missed by conventional methods. These programs correlate with patient survival and key cancer hallmarks: initiation, proliferation, and immune evasion. Altogether, we show splicing factor activity can be accurately estimated from exon inclusion changes, enabling comprehensive analyses of splicing regulation with minimal data requirements.

摘要

剪接因子控制信使核糖核酸中的外显子包含情况,塑造转录组和蛋白质组的多样性。它们的催化活性受到多层调控,仅靠单一组学测量不足以确定导致某种表型的剪接因子。在此,我们提出可以通过解释外显子包含情况的变化来估计剪接因子活性。我们对构建剪接因子→外显子网络及计算活性的方法进行了基准测试。将基于RNA测序扰动的网络与VIPER(通过富集调控子分析进行蛋白质活性的虚拟推断)相结合,能够准确捕捉受不同调控层调节的剪接因子激活情况。这种方法将剪接因子调控整合为一个仅从外显子包含特征得出的单一分数,从而能够对异质性条件进行功能解释。作为概念验证,我们识别出复发性癌症剪接程序,揭示了传统方法遗漏的致癌和抑癌样剪接因子。这些程序与患者生存率及关键癌症特征相关:起始、增殖和免疫逃逸。总之,我们表明可以从外显子包含变化准确估计剪接因子活性,从而能够以最少的数据需求对剪接调控进行全面分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fe/11781469/ca0a1a994632/nihpp-2024.06.21.600051v3-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fe/11781469/75ddc9ee7f43/nihpp-2024.06.21.600051v3-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fe/11781469/121b0bef463e/nihpp-2024.06.21.600051v3-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fe/11781469/186d8e8f54a3/nihpp-2024.06.21.600051v3-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fe/11781469/71030ea5590b/nihpp-2024.06.21.600051v3-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fe/11781469/ca0a1a994632/nihpp-2024.06.21.600051v3-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fe/11781469/75ddc9ee7f43/nihpp-2024.06.21.600051v3-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fe/11781469/121b0bef463e/nihpp-2024.06.21.600051v3-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fe/11781469/186d8e8f54a3/nihpp-2024.06.21.600051v3-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fe/11781469/71030ea5590b/nihpp-2024.06.21.600051v3-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8fe/11781469/ca0a1a994632/nihpp-2024.06.21.600051v3-f0005.jpg

相似文献

1
Exon inclusion signatures enable accurate estimation of splicing factor activity.外显子包含特征能够准确估计剪接因子活性。
bioRxiv. 2025 Jan 30:2024.06.21.600051. doi: 10.1101/2024.06.21.600051.
2
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
5
How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis.疾病轨迹的生活经历、治疗负担和社会不平等如何影响服务使用者和照顾者参与健康和社会护理:一项基于理论的定性证据综合分析
Health Soc Care Deliv Res. 2025 Jun;13(24):1-120. doi: 10.3310/HGTQ8159.
6
Methods for managing miscarriage: a network meta-analysis.流产管理方法:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jun 1;6(6):CD012602. doi: 10.1002/14651858.CD012602.pub2.
7
How to Implement Digital Clinical Consultations in UK Maternity Care: the ARM@DA Realist Review.如何在英国产科护理中实施数字临床会诊:ARM@DA实证主义综述
Health Soc Care Deliv Res. 2025 May 21:1-77. doi: 10.3310/WQFV7425.
8
Education support services for improving school engagement and academic performance of children and adolescents with a chronic health condition.改善患有慢性病的儿童和青少年的学校参与度和学业成绩的教育支持服务。
Cochrane Database Syst Rev. 2023 Feb 8;2(2):CD011538. doi: 10.1002/14651858.CD011538.pub2.
9
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.肺炎球菌结合疫苗的免疫原性和血清效力:系统评价和网络荟萃分析。
Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079.
10
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.

本文引用的文献

1
Reverse engineering neuron-type-specific and type-orthogonal splicing-regulatory networks using diverse cellular transcriptomes.利用多样的细胞转录组反向工程神经元类型特异性和类型正交剪接调控网络。
Cell Rep. 2025 Jun 24;44(7):115898. doi: 10.1016/j.celrep.2025.115898.
2
Molecular impact of mutations in RNA splicing factors in cancer.RNA 剪接因子突变在癌症中的分子影响。
Mol Cell. 2024 Oct 3;84(19):3667-3680. doi: 10.1016/j.molcel.2024.07.019. Epub 2024 Aug 14.
3
Unique transcriptomes of sensory and non-sensory neurons: insights from Splicing Regulatory States.
感觉神经元和非感觉神经元的独特转录组:拼接调控状态的见解。
Mol Syst Biol. 2024 Apr;20(4):296-310. doi: 10.1038/s44320-024-00020-1. Epub 2024 Mar 4.
4
A comprehensive clinically informed map of dependencies in cancer cells and framework for target prioritization.癌症细胞中依赖关系的全面临床信息图和目标优先级划分框架。
Cancer Cell. 2024 Feb 12;42(2):301-316.e9. doi: 10.1016/j.ccell.2023.12.016. Epub 2024 Jan 11.
5
RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing.RBFOX2 失调通过选择性剪接促进胰腺癌的进展和转移。
Nat Commun. 2023 Dec 19;14(1):8444. doi: 10.1038/s41467-023-44126-w.
6
Expanding the coverage of regulons from high-confidence prior knowledge for accurate estimation of transcription factor activities.从高可信度的先验知识中扩展调控网络的覆盖范围,以准确估计转录因子的活性。
Nucleic Acids Res. 2023 Nov 10;51(20):10934-10949. doi: 10.1093/nar/gkad841.
7
Partial gene suppression improves identification of cancer vulnerabilities when CRISPR-Cas9 knockout is pan-lethal.部分基因抑制可改善 CRISPR-Cas9 基因敲除泛致死时癌症脆弱性鉴定。
Genome Biol. 2023 Aug 23;24(1):192. doi: 10.1186/s13059-023-03020-w.
8
decoupleR: ensemble of computational methods to infer biological activities from omics data.decoupleR:用于从组学数据推断生物活性的计算方法集合。
Bioinform Adv. 2022 Mar 8;2(1):vbac016. doi: 10.1093/bioadv/vbac016. eCollection 2022.
9
RNA splicing dysregulation and the hallmarks of cancer.RNA 剪接失调与癌症的特征。
Nat Rev Cancer. 2023 Mar;23(3):135-155. doi: 10.1038/s41568-022-00541-7. Epub 2023 Jan 10.
10
Regulation of pre-mRNA splicing: roles in physiology and disease, and therapeutic prospects.前体mRNA剪接的调控:在生理和疾病中的作用以及治疗前景。
Nat Rev Genet. 2023 Apr;24(4):251-269. doi: 10.1038/s41576-022-00556-8. Epub 2022 Dec 16.